Audio By Carbonatix
Uganda will begin human trials of a Covid-19 vaccine in November, the Daily Monitor newspaper reports quoting ministry of health officials.
The vaccine, called Self Replicating RNA, has been developed through a partnership between Uganda Virus Research Institute (UVRI) and Imperial College in the UK.
The head of a presidential taskforce on epidemics, Monica Musenero, is quoted as saying the first trial will be conducted on 10 Ugandans.
If successful, a second trial will involve about 100 to 200 people followed by a final trial of between 1,000 and 3,000 people, she said.
The bulk of the project is being financed by the UK university.
The East Africa country has to date confirmed more than 7,000 coronavirus cases and 75 deaths.
Latest Stories
-
Morocco and Senegal set for defining AFCON final under Rabat lights today
59 minutes -
Trump tariff threat over Greenland ‘unacceptable’, European leaders say
1 hour -
Evalue-Ajomoro-Gwira MP kicks against VALCO sale
2 hours -
Mercy Johnson withdraws alleged defamation case against TikToker
3 hours -
Ghana accepted Trump’s deported West Africans and forced them back to their native countries
3 hours -
No evidence of theft in Unibank Case – A‑G explains withdrawal of charges against Dr Duffour
3 hours -
Labourer remanded for threatening to kill mother
3 hours -
Court remands farmer over GH¢110,000 car fraud
4 hours -
Tension mounts at Akyem Akroso over ‘sale’ of royal cemetery
4 hours -
Poor planning fueling transport crisis—Prof. Beyuo
5 hours -
Ahiagbah slams Prof. Frimpong-Boateng over “fake” party slur
5 hours -
Family traumatised as body of Presby steward goes ‘missing’ at mortuary
5 hours -
Why Ghana must maintain the NPA’s price floor in the petroleum market
6 hours -
Serwaa Amihere apologises to PRESEC community over ‘homosexual breeding ground’ comment
7 hours -
Dr Arthur Kennedy slams NPP’s “dubious” plot to expel Prof Frimpong-Boateng
7 hours